Study of the Stability of Factor VIII Activity in Human Plasma for Fractionation When Modeling Deviations in the Storage and Transportation Temperature Conditions
The European Pharmacopoeia requires that the transportation and storage of human plasma for fractionation should be carried out at –20 °C or below, while allowing for some deviations in the temperature regime. The current Russian regulatory documentation requires the transportation and storage of pl...
Saved in:
| Main Authors: | A. A. Gorodkov, A. L. Poptsov, A. L. Khokhryakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2020-09-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/285 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: Effects on plasma proteins and coagulation factor VIII
by: Stanojković Zoran, et al.
Published: (2011-01-01) -
Preparation of Plasma-based Medicinal Products in Combating Coagulation Factors Deficiencies by Apheresis Technique
by: Dunya, Y.*, Bukar, A., Obi, S.O., Medugu, J.T., Waziri, N.S., John, W.K., Mela, T.S., Halima, I., Azuike, C.G.
Published: (2025-05-01) -
Plasma Freezing Quality under Action of Magnetic Field
by: Lan Hui, et al.
Published: (2022-01-01) -
Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease
by: R. M. Imtiaz Karim Rony, et al.
Published: (2025-07-01) -
Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study
by: Syna Miri, et al.
Published: (2024-11-01)